Biogen Idec [BIIB] CEO To Ring The NASDAQ Stock Market Opening Bell

NEW YORK, May 18 /PRNewswire-FirstCall/ -- The following is being issued by NASDAQ :

What: Jim Mullen, CEO of Biogen Idec will preside over the opening bell to celebrate the 10th Anniversary of blockbuster multiple sclerosis drug, AVONEX(R) (Interferon beta-1a). Where: NASDAQ MarketSite - 4 Times Square - 43rd & Broadway - Broadcast Studio When: Friday, May 19th, 2006 at 9:30 a.m. EDT Contacts: Biogen Idec: Amy Brockelman Sr. Manager, Public Affairs 617-914-6524 NASDAQ MarketSite: Stephanie Lowenthal; 646.441.5220 Feed Information: The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA-5 C-band/transponder 14. The downlink frequency is 3980 horizontal; audio: 6.2/6.8. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Stephanie Lowenthal at (646) 441-5220. Photos: To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice. About Biogen Idec [BIIB]:

Biogen Idec creates new standards of care in oncology, neurology and immunology. As a global leader in the development, manufacturing, and commercialization of novel therapies, Biogen Idec transforms scientific discoveries into advances in human healthcare. For product labeling, press releases and additional information about the company, please visit http://www.biogenidec.com.

NASDAQ

CONTACT: Amy Brockelman, Sr. Manager, Public Affairs, of Biogen Idec,+1-617-914-6524; or Stephanie Lowenthal of NASDAQ MarketSite,+1-646-441-5220

Back to news